Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Powell

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Improvement of long-term survival in extensive small-cell lung cancerD V Jackson, L D Case, P J Zekan, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Blood|May 26, 1999
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364M S Czuczman, R K Dodge, C C Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Improvement of long-term survival in extensive small-cell lung cancerD V Jackson, L D Case, P J Zekan, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Blood|May 26, 1999
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364M S Czuczman, R K Dodge, C C Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Pageof 10